Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survivalNikiforos-Ioannis Kapetanakis, Pierre Busson|Oncotarget|2015Cited by 34